On September 2, 2020 Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, reported that Jounce management will participate in fireside chats at three upcoming investor conferences in September (Press release, Jounce Therapeutics, SEP 2, 2020, View Source [SID1234564290]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2020 Global Healthcare Conference at 12:50 p.m. ET on Wednesday, September 9, 2020.
2020 Wells Fargo Virtual Healthcare Conference at 3:20 p.m. ET on Thursday, September 10, 2020.
H.C. Wainwright 22nd Annual Healthcare Conference at 3:00 p.m. ET on Monday, September 14, 2020.
A live webcast of each presentation will be available by visiting "Events & Presentations" in the Investors and Media section of the company’s website at www.jouncetx.com. A replay of the webcast will be archived for 30 days following the presentation.